Literature DB >> 8562634

Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites.

D D Baird1, D R McConnaughey, C R Weinberg, P I Musey, D C Collins, J S Kesner, E A Knecht, A J Wilcox.   

Abstract

Longitudinal epidemiologic studies of menstrual and reproductive function are more informative if one can identify day of ovulation. We previously developed a method for estimating day of ovulation that is feasible for epidemiologic studies. The method relies on the relative concentrations of estrogen and progesterone metabolites in daily first-morning urine specimens and does not require creatinine adjustment. This paper describes results of applying this method to a large study with 724 menstrual cycles from 217 women. The method estimated a credible day of ovulation in 88% of cycles. Missing data accounted for most of the failures. When we excluded anovulatory cycles (1%) and cycles with missing data, the method estimated a day of ovulation in 97% of cycles. Variance in luteal phase length was small for our sample, suggesting that this method of identifying a day of ovulation introduces no more measurement error than when day of ovulation is determined by plasma luteinizing hormone (LH), the standard clinical method.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562634     DOI: 10.1097/00001648-199509000-00015

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  29 in total

1.  Conceptual model for assessment of dermal exposure.

Authors:  T Schneider; R Vermeulen; D H Brouwer; J W Cherrie; H Kromhout; C L Fogh
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

2.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

3.  Effects of early pregnancy loss on hormone levels in the subsequent menstrual cycle.

Authors:  Anne Marie Z Jukic; Clarice R Weinberg; Allen J Wilcox; Donna D Baird
Journal:  Gynecol Endocrinol       Date:  2010-05-26       Impact factor: 2.260

4.  Terms in reproductive and perinatal epidemiology: I. Reproductive terms.

Authors:  Ruby H N Nguyen; Allen J Wilcox
Journal:  J Epidemiol Community Health       Date:  2005-11       Impact factor: 3.710

5.  Associations between urinary biomarkers of polycyclic aromatic hydrocarbon exposure and reproductive function during menstrual cycles in women.

Authors:  Ulrike Luderer; Fletcher Christensen; Wesley O Johnson; Jianwen She; Ho Sai Simon Ip; Junqiang Zhou; Josephine Alvaran; Edward F Krieg; James S Kesner
Journal:  Environ Int       Date:  2017-01-05       Impact factor: 9.621

6.  Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation.

Authors:  Nanette Santoro; Sybil L Crawford; Samar R El Khoudary; Amanda A Allshouse; Sherri-Ann Burnett-Bowie; Joel Finkelstein; Carol Derby; Karen Matthews; Howard M Kravitz; Sioban D Harlow; Gail A Greendale; Ellen B Gold; Rasa Kazlauskaite; Dan McConnell; Genevieve Neal-Perry; Jelena Pavlovic; John Randolph; Gerson Weiss; Hsiang-Yu Chen; Bill Lasley
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

7.  Routine assessment of ovulation is unlikely to be medically necessary among eumenorrheic women.

Authors:  Elizabeth A DeVilbiss; Lindsey A Sjaarda; Sunni L Mumford
Journal:  Fertil Steril       Date:  2020-09-06       Impact factor: 7.329

8.  Menstrual cycle perturbation by organohalogens and elements in the Cree of James Bay, Canada.

Authors:  Bruce C Wainman; James S Kesner; Ian D Martin; Juliana W Meadows; Edward F Krieg; Evert Nieboer; Leonard J Tsuji
Journal:  Chemosphere       Date:  2016-02-06       Impact factor: 7.086

9.  Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials.

Authors:  Sholom Wacholder; Bingshu Eric Chen; Allen Wilcox; George Macones; Paula Gonzalez; Brian Befano; Allan Hildesheim; Ana Cecilia Rodríguez; Diane Solomon; Rolando Herrero; Mark Schiffman
Journal:  BMJ       Date:  2010-03-02

10.  Lifestyle and reproductive factors associated with follicular phase length.

Authors:  Anne Marie Zaura Jukic; Clarice R Weinberg; Donna D Baird; Allen J Wilcox
Journal:  J Womens Health (Larchmt)       Date:  2007-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.